Table of Contents
Overview
New York, NY – July 09, 2026 – The Global Human Chorionic Gonadotropin Market Size is expected to be worth around US$ 1.5 billion by 2034 from US$ 0.8 billion in 2024, growing at a CAGR of 6.7% during the forecast period 2025 to 2034.
Human Chorionic Gonadotropin (hCG) is a naturally occurring hormone produced primarily during pregnancy by cells that form the placenta. It plays an important role in supporting early pregnancy by stimulating the production of progesterone, a hormone that helps maintain the uterine lining and supports fetal development.
hCG is widely recognized as a key biomarker used in pregnancy testing. Its presence in blood or urine can be detected shortly after implantation, making it a reliable indicator for confirming pregnancy in clinical and home-testing settings.
Beyond pregnancy detection, hCG has several established medical applications. In reproductive medicine, it may be used as part of fertility treatment protocols to support ovulation in women and stimulate testosterone production in certain male fertility treatments. hCG is also used in specific diagnostic evaluations under the guidance of healthcare professionals.
The hormone is available in pharmaceutical formulations and is administered under medical supervision when used for therapeutic purposes. Its use should follow approved medical indications, dosage recommendations, and safety guidelines.
As research in reproductive health and endocrinology continues to evolve, hCG remains an important hormone in both diagnostic and therapeutic contexts. Healthcare providers can determine the appropriate use of hCG based on individual patient needs and clinical circumstances.
Key Takeaways
- The global Human Chorionic Gonadotropin market generated US$ 0.8 Billion in revenue in 2024 and is projected to reach US$ 1.5 Billion by 2034, expanding at a CAGR of 6.7% during the forecast period.
- By product type, the market is segmented into native and recombinant HCG. The native segment held the leading position in 2023, accounting for 56.3% of the market share.
- Based on therapeutic area, the market is categorized into female infertility treatment, male hypogonadism, chronic pain, and others. Among these, female infertility treatment dominated the market with a 54.8% share.
- In terms of distribution channel, the market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies. Hospital pharmacies emerged as the dominant segment, contributing 63.9% of the total revenue.
- North America led the regional market in 2023, capturing a 43.2% share of the global human chorionic gonadotropin market.
Regional Analysis
North America held the largest share of the Human Chorionic Gonadotropin (hCG) market in 2024, accounting for 43.2% of global revenue. Market growth was mainly supported by the rising prevalence of infertility and the increasing adoption of assisted reproductive technologies (ART), in which hCG is widely used for ovulation induction and pregnancy support.
According to the Centers for Disease Control and Prevention, the number of babies born from in vitro fertilization (IVF) cycles in the United States increased from 89,208 in 2021 to 91,771 in 2022, highlighting continued growth in ART procedures.
Demand for hCG was also supported by its diagnostic applications, including early pregnancy detection and monitoring of gynecological conditions. In addition, Organon reported a 7% increase in Women’s Health revenue in the fourth quarter of 2023, driven largely by strong performance in fertility products.
The Asia Pacific region is expected to register the highest CAGR during the forecast period. Growth in this region is attributed to increasing infertility rates, greater awareness of fertility treatments, and ongoing improvements in healthcare infrastructure.
The World Health Organization estimates that about 17.5% of adults globally experience infertility, indicating a substantial unmet need in populous countries such as China and India. Expanding investments in fertility clinics and advanced treatment protocols, along with the growing presence of companies such as Merck KGaA, are expected to further accelerate demand for hCG in Asia Pacific.
Emerging Trends
- Regulatory clarity for OTC hCG test kits: Regulatory agencies, including the FDA, are refining guidance for over-the-counter hCG pregnancy test kits by defining performance standards and safety requirements. This trend is driven by rising consumer demand for reliable home diagnostics and efforts to reduce unnecessary clinical visits.
- Expansion of point-of-care quantitative hCG testing: Point-of-care quantitative hCG testing is increasingly used in Early Pregnancy Assessment Units to monitor serial hormone levels every 48 hours. This approach helps distinguish normal intrauterine pregnancies from failing or ectopic pregnancies, enabling earlier clinical decisions and personalized patient management.
- Research into anti-inflammatory properties of hCG: Preclinical research is exploring hCG’s anti-inflammatory potential beyond its established reproductive functions. Animal studies suggest that hCG may modulate inflammatory pathways, indicating possible future applications in autoimmune and inflammatory disorders as understanding of its cytokine-like effects expands.
- Development of hCG-based immunotherapies: Immunological applications of hCG are being investigated through vaccines targeting the hCG β-subunit for contraceptive and cancer therapy purposes. Early studies indicate that anti-hCG antibodies may inhibit embryo implantation and potentially serve as tumor-targeting agents in trophoblastic cancers.
Use Cases
- Early pregnancy detection and monitoring: β-hCG can be detected in blood as early as eight days after ovulation, enabling early pregnancy diagnosis. In viable intrauterine pregnancies with initial β-hCG below 1,500 mIU/mL, levels typically rise by at least 49 percent within 48 hours.
- Assisted reproductive technology (ART): In IVF protocols, hCG is administered to support final oocyte maturation and maintain the luteal phase. Patients commonly receive intramuscular injections before embryo transfer and afterward, contributing to implantation rates exceeding 30 percent per transfer.
- Ectopic pregnancy management: Quantitative hCG measurements play a critical role in diagnosing ectopic pregnancy. Plateauing or declining serial hCG levels, particularly a decrease of 21 percent or more over 48 hours, indicate a likely nonviable pregnancy and prompt additional imaging or intervention.
- Contraceptive initiation and counseling: Qualitative urine hCG tests with approximately 95 percent sensitivity at 25 mIU/mL are recommended before initiating certain contraceptive methods. This practice helps rule out existing pregnancy and reduces the risk of unintended fetal exposure to teratogenic contraceptives.
Frequently Asked Questions on Human Chorionic Gonadotropin
- What is Human Chorionic Gonadotropin (hCG)?
Human chorionic gonadotropin (hCG) is a hormone produced mainly during pregnancy by the placenta. It supports the corpus luteum, helps maintain progesterone production, and is widely used in pregnancy testing and fertility treatment protocols. - How is hCG used in fertility treatment?
In fertility treatment, hCG is administered to trigger ovulation and support the final maturation of eggs before assisted reproductive procedures. It is commonly used in in vitro fertilization (IVF) and other assisted reproductive technology (ART) protocols. - What are the diagnostic uses of hCG?
hCG is primarily used in diagnostic applications for confirming pregnancy through blood or urine tests. It may also assist healthcare professionals in monitoring certain gynecological conditions and evaluating treatment progress in reproductive health care. - What factors are increasing demand for hCG?
Demand for hCG is increasing due to rising infertility rates, delayed parenthood, greater awareness of fertility treatments, and expanding access to assisted reproductive technologies. Growing diagnostic testing and improved healthcare infrastructure also contribute to market demand. - Why is North America leading the hCG market?
North America leads the hCG market because of its high adoption of assisted reproductive technologies, advanced healthcare infrastructure, and strong awareness of fertility treatments. The region also benefits from significant pharmaceutical presence and consistent demand for reproductive health products. - Which region is expected to grow fastest in the hCG market?
Asia Pacific is expected to experience the highest growth in the hCG market during the forecast period. Increasing infertility rates, improving healthcare infrastructure, rising disposable incomes, and expanding access to fertility treatments are major drivers. - What role does hCG play in assisted reproductive technologies?
hCG plays a crucial role in assisted reproductive technologies by inducing ovulation and supporting the final maturation of ovarian follicles. Its use helps improve the timing and effectiveness of procedures such as IVF and intrauterine insemination. - Who are the key players in the hCG market?
Key players in the hCG market include pharmaceutical and biotechnology companies with strong reproductive health portfolios. Companies such as Organon and Merck KGaA are notable participants, contributing through product development, regional expansion, and fertility treatment solutions.
Conclusion
Human Chorionic Gonadotropin (hCG) remains a vital hormone in reproductive healthcare, serving both diagnostic and therapeutic purposes. Its widespread use in pregnancy detection, fertility treatment, and assisted reproductive technologies underscores its clinical importance. The global hCG market is expected to grow steadily, driven by rising infertility rates, increasing adoption of ART procedures, and expanding awareness of reproductive health.
North America currently leads the market due to healthcare infrastructure and strong demand for fertility treatments, while Asia Pacific is projected to experience the fastest growth. Continued research, regulatory developments, and innovations in hCG-based applications are expected to strengthen its role in medicine.
Discuss your needs with our analyst
Please share your requirements with more details so our analyst can check if they can solve your problem(s)
